SERPINB3 and hepatocellular carcinoma: Previous studies that used an antibody-based immune blotting method reported that GPC3 [18,19] and SCCA [20,21] were elevated in 50% and 70% of HCC patients, respectively, and suggested that these proteins were useful tools for early diagnosis of HCC.